We are consulting on proposals to amend the Branded Health Service Medicines (Costs) Regulations 2018 to restore broad commercial equivalence with the voluntary scheme for branded medicines pricing, access and growth (VPAG). The consultation will propose to update the payment percentage for newer medicines and simplify the procedure for future consultations.
We welcome responses from any interested person, business or organisation.
Please review the full consultation page before completing this survey.
If you navigate away from the survey, your progress will be automatically saved. If you reopen the link in the same browser that you started the survey, you will be able to continue your response.
This survey will close at 11.59pm on 21 April 2026.